Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative...

Area of Science:

• Urology
• Oncology
• Biomaterials Science

Background:

• Non-muscular invasive bladder cancer (NMIBC) presents a significant health and economic burden.
• NMIBC progression includes low-grade (Ta) and high-grade (carcinoma in situ, T1) stages.
• Current treatments like transurethral resection and BCG immunotherapy have limitations in efficacy and recurrence control.

Purpose of the Study:

• To comprehensively analyze the therapeutic journey for NMIBC treatment.
• To evaluate traditional and emerging regenerative interventions for NMIBC management.
• To explore the role of biomaterials and scaffolds in bladder cancer therapy.

Main Methods:

• Review of traditional NMIBC treatments (surgery, BCG, chemotherapy).
• Analysis of regenerative therapies including stem cells and platelet-rich plasma (PRP).
• Exploration of biomaterials and scaffolds for therapeutic agent delivery and bladder reconstruction.

Main Results:

• Traditional therapies show limited efficacy in controlling NMIBC and preventing long-term recurrence.
• Biomaterials and scaffolds offer potential for targeted drug delivery and tissue regeneration.
• Regenerative approaches like stem cells and PRP show promise for NMIBC treatment.

Conclusions:

• There is a need for more effective and comprehensive NMIBC treatment strategies.
• Biomaterials and regenerative medicine hold significant potential for advancing NMIBC therapy.
• Further research into integrated therapeutic approaches is warranted for improved patient outcomes.